

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cornea development in camera-type eye (GO:0061303) | 6.65060934 |
| 2 | keratinocyte development (GO:0003334) | 5.93828269 |
| 3 | regulation of hexokinase activity (GO:1903299) | 5.39926402 |
| 4 | regulation of glucokinase activity (GO:0033131) | 5.39926402 |
| 5 | lactate metabolic process (GO:0006089) | 4.57618949 |
| 6 | dorsal/ventral axis specification (GO:0009950) | 4.28558144 |
| 7 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.08626790 |
| 8 | DNA double-strand break processing (GO:0000729) | 4.08427995 |
| 9 | regulation of timing of cell differentiation (GO:0048505) | 3.93879575 |
| 10 | low-density lipoprotein particle clearance (GO:0034383) | 3.90725520 |
| 11 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.84817155 |
| 12 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.84817155 |
| 13 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.84817155 |
| 14 | hindbrain development (GO:0030902) | 3.66674679 |
| 15 | intestinal epithelial cell development (GO:0060576) | 3.66669342 |
| 16 | positive regulation of glycolytic process (GO:0045821) | 3.64479825 |
| 17 | positive regulation of protein autophosphorylation (GO:0031954) | 3.62213787 |
| 18 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.48798481 |
| 19 | Golgi transport vesicle coating (GO:0048200) | 3.43612866 |
| 20 | COPI coating of Golgi vesicle (GO:0048205) | 3.43612866 |
| 21 | regulation of development, heterochronic (GO:0040034) | 3.42804439 |
| 22 | regulation of B cell apoptotic process (GO:0002902) | 3.35564059 |
| 23 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.34284939 |
| 24 | negative regulation of neurological system process (GO:0031645) | 3.33902343 |
| 25 | synapsis (GO:0007129) | 3.33040500 |
| 26 | inositol phosphate catabolic process (GO:0071545) | 3.25331419 |
| 27 | positive regulation of cell fate commitment (GO:0010455) | 3.24962080 |
| 28 | astrocyte differentiation (GO:0048708) | 3.24586775 |
| 29 | glial cell proliferation (GO:0014009) | 3.18536875 |
| 30 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.18497686 |
| 31 | platelet dense granule organization (GO:0060155) | 3.12850280 |
| 32 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.11777214 |
| 33 | RNA destabilization (GO:0050779) | 3.07715999 |
| 34 | protein prenylation (GO:0018342) | 3.07057818 |
| 35 | prenylation (GO:0097354) | 3.07057818 |
| 36 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.04381196 |
| 37 | prostate gland growth (GO:0060736) | 3.04289140 |
| 38 | natural killer cell mediated immunity (GO:0002228) | 3.01870016 |
| 39 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.01870016 |
| 40 | protein targeting to Golgi (GO:0000042) | 3.01523812 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.99712693 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.99712693 |
| 43 | modulation by symbiont of host immune response (GO:0052553) | 2.99712693 |
| 44 | positive regulation by symbiont of host defense response (GO:0052509) | 2.99712693 |
| 45 | modulation by symbiont of host defense response (GO:0052031) | 2.99712693 |
| 46 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.99712693 |
| 47 | polyol catabolic process (GO:0046174) | 2.98480079 |
| 48 | response to pheromone (GO:0019236) | 2.97771220 |
| 49 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.96799038 |
| 50 | pancreas development (GO:0031016) | 2.95445508 |
| 51 | positive regulation of nuclease activity (GO:0032075) | 2.95285647 |
| 52 | indole-containing compound catabolic process (GO:0042436) | 2.95094341 |
| 53 | indolalkylamine catabolic process (GO:0046218) | 2.95094341 |
| 54 | tryptophan catabolic process (GO:0006569) | 2.95094341 |
| 55 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.94338217 |
| 56 | protein K11-linked deubiquitination (GO:0035871) | 2.91503351 |
| 57 | heterochromatin organization (GO:0070828) | 2.90715074 |
| 58 | signal peptide processing (GO:0006465) | 2.89472065 |
| 59 | establishment of protein localization to Golgi (GO:0072600) | 2.87142984 |
| 60 | negative regulation of dendrite development (GO:2000171) | 2.85514884 |
| 61 | tetrahydrofolate metabolic process (GO:0046653) | 2.84574937 |
| 62 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.84049214 |
| 63 | regulation of translational fidelity (GO:0006450) | 2.84035813 |
| 64 | ER overload response (GO:0006983) | 2.83574915 |
| 65 | cell adhesion mediated by integrin (GO:0033627) | 2.80784291 |
| 66 | positive regulation of macroautophagy (GO:0016239) | 2.80124644 |
| 67 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.78710485 |
| 68 | regulation of nuclease activity (GO:0032069) | 2.77879397 |
| 69 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.77157508 |
| 70 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.76413889 |
| 71 | insulin secretion (GO:0030073) | 2.76135887 |
| 72 | glandular epithelial cell differentiation (GO:0002067) | 2.75576222 |
| 73 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.74826131 |
| 74 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.74826131 |
| 75 | isotype switching (GO:0045190) | 2.74826131 |
| 76 | regulation of translational termination (GO:0006449) | 2.74371023 |
| 77 | pre-miRNA processing (GO:0031054) | 2.74102914 |
| 78 | replication fork processing (GO:0031297) | 2.73042043 |
| 79 | regulation of cholesterol storage (GO:0010885) | 2.72439063 |
| 80 | histone H2A acetylation (GO:0043968) | 2.72337419 |
| 81 | DNA deamination (GO:0045006) | 2.70719662 |
| 82 | atrial cardiac muscle cell action potential (GO:0086014) | 2.70398126 |
| 83 | cellular response to unfolded protein (GO:0034620) | 2.70160083 |
| 84 | regulation of protein autophosphorylation (GO:0031952) | 2.69554408 |
| 85 | regulation of meiosis I (GO:0060631) | 2.68308755 |
| 86 | histone mRNA catabolic process (GO:0071044) | 2.68135747 |
| 87 | nuclear pore complex assembly (GO:0051292) | 2.68010386 |
| 88 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.67372652 |
| 89 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.66607458 |
| 90 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.66577468 |
| 91 | zinc ion transport (GO:0006829) | 2.66070214 |
| 92 | respiratory chain complex IV assembly (GO:0008535) | 2.66016776 |
| 93 | negative regulation of acute inflammatory response (GO:0002674) | 2.64536973 |
| 94 | proteasome assembly (GO:0043248) | 2.63873793 |
| 95 | apoptotic cell clearance (GO:0043277) | 2.63782907 |
| 96 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.63230396 |
| 97 | inositol phosphate dephosphorylation (GO:0046855) | 2.63230396 |
| 98 | glandular epithelial cell development (GO:0002068) | 2.62901208 |
| 99 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.62632929 |
| 100 | histone H2A ubiquitination (GO:0033522) | 2.61992550 |
| 101 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.61813618 |
| 102 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.61813618 |
| 103 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.61813618 |
| 104 | positive regulation of response to nutrient levels (GO:0032109) | 2.61730810 |
| 105 | positive regulation of response to extracellular stimulus (GO:0032106) | 2.61730810 |
| 106 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.61644364 |
| 107 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.61607173 |
| 108 | regulation of Rac protein signal transduction (GO:0035020) | 2.59875201 |
| 109 | single strand break repair (GO:0000012) | 2.59447283 |
| 110 | nuclear pore organization (GO:0006999) | 2.58617043 |
| 111 | kynurenine metabolic process (GO:0070189) | 2.57459554 |
| 112 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.57260740 |
| 113 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.57260740 |
| 114 | parental behavior (GO:0060746) | 2.57094602 |
| 115 | positive regulation of neuroblast proliferation (GO:0002052) | 2.56662113 |
| 116 | positive regulation of histone deacetylation (GO:0031065) | 2.55030774 |
| 117 | protein localization to endosome (GO:0036010) | 2.55023239 |
| 118 | ER-nucleus signaling pathway (GO:0006984) | 2.54663859 |
| 119 | COPII vesicle coating (GO:0048208) | 2.54355339 |
| 120 | positive regulation of p38MAPK cascade (GO:1900745) | 2.54176586 |
| 121 | regulation of cholesterol homeostasis (GO:2000188) | 2.52990954 |
| 122 | pentose-phosphate shunt (GO:0006098) | 2.52075576 |
| 123 | cytochrome complex assembly (GO:0017004) | 2.49927174 |
| 124 | cellular response to arsenic-containing substance (GO:0071243) | 2.49694858 |
| 125 | response to arsenic-containing substance (GO:0046685) | 2.49664038 |
| 126 | mRNA stabilization (GO:0048255) | 2.49275706 |
| 127 | RNA stabilization (GO:0043489) | 2.49275706 |
| 128 | plasma lipoprotein particle clearance (GO:0034381) | 2.48765682 |
| 129 | protein localization to cilium (GO:0061512) | 2.47144770 |
| 130 | endocrine pancreas development (GO:0031018) | 2.46763242 |
| 131 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.46332186 |
| 132 | regulation of protein glycosylation (GO:0060049) | 2.46159176 |
| 133 | cellular response to topologically incorrect protein (GO:0035967) | 2.45997956 |
| 134 | gastrulation with mouth forming second (GO:0001702) | 2.43883056 |
| 135 | regulation of sulfur metabolic process (GO:0042762) | 2.43060924 |
| 136 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.41640043 |
| 137 | hepatocyte apoptotic process (GO:0097284) | 2.40798308 |
| 138 | protein localization to kinetochore (GO:0034501) | 2.40541702 |
| 139 | neural tube formation (GO:0001841) | 2.40254543 |
| 140 | response to laminar fluid shear stress (GO:0034616) | 2.39476024 |
| 141 | embryonic foregut morphogenesis (GO:0048617) | 2.37330156 |
| 142 | regulation of podosome assembly (GO:0071801) | 2.37236786 |
| 143 | cell wall macromolecule catabolic process (GO:0016998) | 2.37103578 |
| 144 | kidney morphogenesis (GO:0060993) | 2.36753505 |
| 145 | response to lipoprotein particle (GO:0055094) | 2.36668240 |
| 146 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.36588350 |
| 147 | cilium morphogenesis (GO:0060271) | 2.35256819 |
| 148 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.35196361 |
| 149 | 4-hydroxyproline metabolic process (GO:0019471) | 2.34470399 |
| 150 | T cell apoptotic process (GO:0070231) | 2.33463416 |
| 151 | maternal placenta development (GO:0001893) | 2.32098783 |
| 152 | response to UV-C (GO:0010225) | 2.31790805 |
| 153 | cysteine metabolic process (GO:0006534) | 2.31229625 |
| 154 | negative regulation of fibrinolysis (GO:0051918) | 2.31016365 |
| 155 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.30260756 |
| 156 | wound healing, spreading of epidermal cells (GO:0035313) | 2.29945369 |
| 157 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.27862008 |
| 158 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.25698109 |
| 159 | NADPH regeneration (GO:0006740) | 2.25344032 |
| 160 | negative regulation of interleukin-12 production (GO:0032695) | 2.21938982 |
| 161 | regulation of chromatin binding (GO:0035561) | 2.21669525 |
| 162 | mitotic nuclear envelope disassembly (GO:0007077) | 2.21312589 |
| 163 | protein carboxylation (GO:0018214) | 2.19889207 |
| 164 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.19889207 |
| 165 | DNA unwinding involved in DNA replication (GO:0006268) | 2.18959844 |
| 166 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.18734406 |
| 167 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.17699343 |
| 168 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.17643358 |
| 169 | skin morphogenesis (GO:0043589) | 2.17290116 |
| 170 | nuclear envelope disassembly (GO:0051081) | 2.16901950 |
| 171 | membrane disassembly (GO:0030397) | 2.16901950 |
| 172 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.16871420 |
| 173 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.16246483 |
| 174 | dosage compensation (GO:0007549) | 2.15769105 |
| 175 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.14109959 |
| 176 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.13919249 |
| 177 | NLS-bearing protein import into nucleus (GO:0006607) | 2.13216898 |
| 178 | folic acid-containing compound metabolic process (GO:0006760) | 2.13205805 |
| 179 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.12912126 |
| 180 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.12861146 |
| 181 | embryonic process involved in female pregnancy (GO:0060136) | 2.11439767 |
| 182 | positive regulation of lipid storage (GO:0010884) | 2.11379448 |
| 183 | pore complex assembly (GO:0046931) | 2.11263844 |
| 184 | response to endoplasmic reticulum stress (GO:0034976) | 2.10487384 |
| 185 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.09411754 |
| 186 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.09306932 |
| 187 | positive regulation of interferon-alpha production (GO:0032727) | 2.06292649 |
| 188 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.06051674 |
| 189 | negative regulation of lipid transport (GO:0032369) | 2.06028232 |
| 190 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.05632864 |
| 191 | glycine metabolic process (GO:0006544) | 2.05503156 |
| 192 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.04494871 |
| 193 | regulation of gamma-delta T cell activation (GO:0046643) | 2.03936357 |
| 194 | apoptotic process involved in morphogenesis (GO:0060561) | 2.02825956 |
| 195 | myeloid cell homeostasis (GO:0002262) | 2.02680374 |
| 196 | regulation of hippo signaling (GO:0035330) | 2.02461807 |
| 197 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.01525066 |
| 198 | regulation of interferon-alpha production (GO:0032647) | 2.01203467 |
| 199 | one-carbon metabolic process (GO:0006730) | 2.00881703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.60766000 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.75073008 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.25913538 |
| 4 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.95093742 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.87366705 |
| 6 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.78614258 |
| 7 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.75920549 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.66682595 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.64668506 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.53045480 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.45769038 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.32986633 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.17914317 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.17610106 |
| 15 | P300_19829295_ChIP-Seq_ESCs_Human | 2.17240983 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.16866567 |
| 17 | FUS_26573619_Chip-Seq_HEK293_Human | 2.16314593 |
| 18 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.14342249 |
| 19 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.11068650 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.10190925 |
| 21 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.09064208 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.04314829 |
| 23 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.03963541 |
| 24 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.03097187 |
| 25 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.99071321 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.98622037 |
| 27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.96247852 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.95819641 |
| 29 | EWS_26573619_Chip-Seq_HEK293_Human | 1.93494595 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.88045626 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84757616 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.82390139 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.78204700 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.78010433 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.77735695 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75475090 |
| 37 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.69996540 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.69505045 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.69008865 |
| 40 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.68929843 |
| 41 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.67458014 |
| 42 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.66395041 |
| 43 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.65583793 |
| 44 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.64771110 |
| 45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.64611496 |
| 46 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.63357820 |
| 47 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.63357820 |
| 48 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62714466 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.62296763 |
| 50 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.62267858 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.61444719 |
| 52 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.60195877 |
| 53 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.59958567 |
| 54 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.58355813 |
| 55 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.55617237 |
| 56 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.55083472 |
| 57 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54653613 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.54587962 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.52812174 |
| 60 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.52253542 |
| 61 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52222120 |
| 62 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.52205589 |
| 63 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.51269544 |
| 64 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.51115884 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50858629 |
| 66 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.50802711 |
| 67 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.50521752 |
| 68 | ATF3_27146783_Chip-Seq_COLON_Human | 1.49985710 |
| 69 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.49970307 |
| 70 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.49424818 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49239633 |
| 72 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48866785 |
| 73 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.48396652 |
| 74 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.48322516 |
| 75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.48180642 |
| 76 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.47007614 |
| 77 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45883504 |
| 78 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.45701107 |
| 79 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.44194689 |
| 80 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43212506 |
| 81 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.42847890 |
| 82 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.42696560 |
| 83 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.42664277 |
| 84 | MAF_26560356_Chip-Seq_TH1_Human | 1.42208242 |
| 85 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.41942735 |
| 86 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41017786 |
| 87 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.38591261 |
| 88 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.38416090 |
| 89 | AR_25329375_ChIP-Seq_VCAP_Human | 1.38132016 |
| 90 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.38095841 |
| 91 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.37623559 |
| 92 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.37593913 |
| 93 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.36700986 |
| 94 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.36422130 |
| 95 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.35909507 |
| 96 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.35653190 |
| 97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.35364536 |
| 98 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.35198472 |
| 99 | UTX_26944678_Chip-Seq_JUKART_Human | 1.34415250 |
| 100 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.33856140 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.33027269 |
| 102 | MYB_26560356_Chip-Seq_TH2_Human | 1.31943645 |
| 103 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.30726468 |
| 104 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.30642877 |
| 105 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30304999 |
| 106 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.29367543 |
| 107 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.29101387 |
| 108 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28214913 |
| 109 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.27845893 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27533065 |
| 111 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.26169332 |
| 112 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.25325962 |
| 113 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.25325962 |
| 114 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24265835 |
| 115 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23582127 |
| 116 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.23199584 |
| 117 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.23155662 |
| 118 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22837152 |
| 119 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22714519 |
| 120 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.22439226 |
| 121 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.22135746 |
| 122 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.21778155 |
| 123 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.21725566 |
| 124 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.21430660 |
| 125 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.21219137 |
| 126 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.20956254 |
| 127 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.20154290 |
| 128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19910429 |
| 129 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.19776388 |
| 130 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.19740303 |
| 131 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.19376309 |
| 132 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.19180843 |
| 133 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19079774 |
| 134 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.18820732 |
| 135 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.18433995 |
| 136 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.17769493 |
| 137 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.16511276 |
| 138 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.16222515 |
| 139 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.16083289 |
| 140 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15425576 |
| 141 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.15335644 |
| 142 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14973111 |
| 143 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.14240987 |
| 144 | MYB_26560356_Chip-Seq_TH1_Human | 1.13962861 |
| 145 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13648349 |
| 146 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12957578 |
| 147 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.12840560 |
| 148 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.12548545 |
| 149 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12548370 |
| 150 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12289620 |
| 151 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11912889 |
| 152 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.11452676 |
| 153 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.10606891 |
| 154 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10590716 |
| 155 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.10434842 |
| 156 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.10129005 |
| 157 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09492944 |
| 158 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09472260 |
| 159 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.09370705 |
| 160 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09324727 |
| 161 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.09302688 |
| 162 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.09017854 |
| 163 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.08998597 |
| 164 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08958645 |
| 165 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08955361 |
| 166 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.08506830 |
| 167 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08395938 |
| 168 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.08177945 |
| 169 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.07822903 |
| 170 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07568324 |
| 171 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07128325 |
| 172 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07065849 |
| 173 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.06746893 |
| 174 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.06395252 |
| 175 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.05063190 |
| 176 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05063190 |
| 177 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04550287 |
| 178 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.04406392 |
| 179 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04365743 |
| 180 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.04220725 |
| 181 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04185419 |
| 182 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03362879 |
| 183 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01729240 |
| 184 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.01446185 |
| 185 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.01383618 |
| 186 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.01320159 |
| 187 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.01195763 |
| 188 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.00658396 |
| 189 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99071351 |
| 190 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98776235 |
| 191 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98093236 |
| 192 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97071287 |
| 193 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.95591953 |
| 194 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.95506493 |
| 195 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95424457 |
| 196 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95424457 |
| 197 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.94734880 |
| 198 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.93717562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003787_abnormal_imprinting | 4.17156132 |
| 2 | MP0008877_abnormal_DNA_methylation | 3.93519778 |
| 3 | MP0006292_abnormal_olfactory_placode | 3.81034321 |
| 4 | MP0008057_abnormal_DNA_replication | 3.31618979 |
| 5 | MP0002638_abnormal_pupillary_reflex | 3.29666549 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.11361157 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 3.08652423 |
| 8 | MP0002938_white_spotting | 2.72361629 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.52258889 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.50181478 |
| 11 | MP0010678_abnormal_skin_adnexa | 2.47674461 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.47269094 |
| 13 | MP0003303_peritoneal_inflammation | 2.38669974 |
| 14 | MP0008789_abnormal_olfactory_epithelium | 2.34040744 |
| 15 | MP0005367_renal/urinary_system_phenotyp | 2.10354282 |
| 16 | MP0000516_abnormal_urinary_system | 2.10354282 |
| 17 | MP0002102_abnormal_ear_morphology | 2.08431699 |
| 18 | MP0009840_abnormal_foam_cell | 2.05774457 |
| 19 | MP0005083_abnormal_biliary_tract | 2.01011514 |
| 20 | MP0003436_decreased_susceptibility_to | 1.97817123 |
| 21 | MP0005410_abnormal_fertilization | 1.94739129 |
| 22 | MP0003121_genomic_imprinting | 1.93899216 |
| 23 | MP0010234_abnormal_vibrissa_follicle | 1.93548845 |
| 24 | MP0005076_abnormal_cell_differentiation | 1.91442294 |
| 25 | MP0005394_taste/olfaction_phenotype | 1.91320113 |
| 26 | MP0005499_abnormal_olfactory_system | 1.91320113 |
| 27 | MP0003566_abnormal_cell_adhesion | 1.90276243 |
| 28 | MP0010307_abnormal_tumor_latency | 1.88806213 |
| 29 | MP0005058_abnormal_lysosome_morphology | 1.82099094 |
| 30 | MP0002139_abnormal_hepatobiliary_system | 1.81050179 |
| 31 | MP0005360_urolithiasis | 1.77702694 |
| 32 | MP0002693_abnormal_pancreas_physiology | 1.76773363 |
| 33 | MP0001944_abnormal_pancreas_morphology | 1.72092110 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.70469544 |
| 35 | MP0005379_endocrine/exocrine_gland_phen | 1.61169596 |
| 36 | MP0009278_abnormal_bone_marrow | 1.61050165 |
| 37 | MP0000613_abnormal_salivary_gland | 1.60495871 |
| 38 | MP0004947_skin_inflammation | 1.60008898 |
| 39 | MP0008058_abnormal_DNA_repair | 1.59978080 |
| 40 | MP0003252_abnormal_bile_duct | 1.57299293 |
| 41 | MP0002090_abnormal_vision | 1.57252214 |
| 42 | MP0003693_abnormal_embryo_hatching | 1.54873623 |
| 43 | MP0005023_abnormal_wound_healing | 1.52483448 |
| 44 | MP0009046_muscle_twitch | 1.49582037 |
| 45 | MP0000569_abnormal_digit_pigmentation | 1.48607487 |
| 46 | MP0005365_abnormal_bile_salt | 1.46961987 |
| 47 | MP0005248_abnormal_Harderian_gland | 1.46758397 |
| 48 | MP0000383_abnormal_hair_follicle | 1.46223693 |
| 49 | MP0006082_CNS_inflammation | 1.38927937 |
| 50 | MP0006054_spinal_hemorrhage | 1.37865208 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.37628280 |
| 52 | MP0003453_abnormal_keratinocyte_physiol | 1.37162247 |
| 53 | MP0001984_abnormal_olfaction | 1.30893522 |
| 54 | MP0006072_abnormal_retinal_apoptosis | 1.30633350 |
| 55 | MP0000858_altered_metastatic_potential | 1.28846921 |
| 56 | MP0005253_abnormal_eye_physiology | 1.24758864 |
| 57 | MP0000609_abnormal_liver_physiology | 1.23250661 |
| 58 | MP0002160_abnormal_reproductive_system | 1.23033886 |
| 59 | MP0003122_maternal_imprinting | 1.22579820 |
| 60 | MP0005084_abnormal_gallbladder_morpholo | 1.21503955 |
| 61 | MP0003448_altered_tumor_morphology | 1.21119423 |
| 62 | MP0002163_abnormal_gland_morphology | 1.20778065 |
| 63 | MP0003786_premature_aging | 1.20507981 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.19498783 |
| 65 | MP0001545_abnormal_hematopoietic_system | 1.19498783 |
| 66 | MP0000685_abnormal_immune_system | 1.18754949 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 1.18270982 |
| 68 | MP0008007_abnormal_cellular_replicative | 1.17728533 |
| 69 | MP0001919_abnormal_reproductive_system | 1.16337621 |
| 70 | MP0004957_abnormal_blastocyst_morpholog | 1.15665642 |
| 71 | MP0005075_abnormal_melanosome_morpholog | 1.15550232 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 1.15071284 |
| 73 | MP0002405_respiratory_system_inflammati | 1.14191230 |
| 74 | MP0002419_abnormal_innate_immunity | 1.13791237 |
| 75 | MP0005464_abnormal_platelet_physiology | 1.12862591 |
| 76 | MP0005000_abnormal_immune_tolerance | 1.12768199 |
| 77 | MP0000372_irregular_coat_pigmentation | 1.12639844 |
| 78 | MP0005085_abnormal_gallbladder_physiolo | 1.12017413 |
| 79 | MP0005257_abnormal_intraocular_pressure | 1.11209926 |
| 80 | MP0001730_embryonic_growth_arrest | 1.10934073 |
| 81 | MP0001835_abnormal_antigen_presentation | 1.10871242 |
| 82 | MP0002751_abnormal_autonomic_nervous | 1.10084892 |
| 83 | MP0001533_abnormal_skeleton_physiology | 1.09573270 |
| 84 | MP0009785_altered_susceptibility_to | 1.09140369 |
| 85 | MP0000647_abnormal_sebaceous_gland | 1.08072762 |
| 86 | MP0003091_abnormal_cell_migration | 1.06576314 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 1.06149333 |
| 88 | MP0004264_abnormal_extraembryonic_tissu | 1.06111724 |
| 89 | MP0001915_intracranial_hemorrhage | 1.05163740 |
| 90 | MP0000427_abnormal_hair_cycle | 1.04811374 |
| 91 | MP0001800_abnormal_humoral_immune | 1.03370036 |
| 92 | MP0001849_ear_inflammation | 1.03318385 |
| 93 | MP0000598_abnormal_liver_morphology | 1.02760449 |
| 94 | MP0002086_abnormal_extraembryonic_tissu | 1.02482538 |
| 95 | MP0005025_abnormal_response_to | 1.02097188 |
| 96 | MP0004197_abnormal_fetal_growth/weight/ | 1.01852299 |
| 97 | MP0010155_abnormal_intestine_physiology | 1.01730685 |
| 98 | MP0005389_reproductive_system_phenotype | 1.01700832 |
| 99 | MP0002452_abnormal_antigen_presenting | 1.01668701 |
| 100 | MP0000350_abnormal_cell_proliferation | 1.01488066 |
| 101 | MP0001845_abnormal_inflammatory_respons | 1.01005615 |
| 102 | MP0003195_calcinosis | 1.00732600 |
| 103 | MP0005646_abnormal_pituitary_gland | 0.99262448 |
| 104 | MP0004808_abnormal_hematopoietic_stem | 0.98120896 |
| 105 | MP0000490_abnormal_crypts_of | 0.97605395 |
| 106 | MP0003111_abnormal_nucleus_morphology | 0.97081677 |
| 107 | MP0000733_abnormal_muscle_development | 0.96677043 |
| 108 | MP0009780_abnormal_chondrocyte_physiolo | 0.95087704 |
| 109 | MP0005387_immune_system_phenotype | 0.94009464 |
| 110 | MP0001790_abnormal_immune_system | 0.94009464 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 0.93318855 |
| 112 | MP0003077_abnormal_cell_cycle | 0.92808465 |
| 113 | MP0003941_abnormal_skin_development | 0.91806674 |
| 114 | MP0002088_abnormal_embryonic_growth/wei | 0.91479523 |
| 115 | MP0003984_embryonic_growth_retardation | 0.91222789 |
| 116 | MP0003186_abnormal_redox_activity | 0.89926016 |
| 117 | MP0002398_abnormal_bone_marrow | 0.89706393 |
| 118 | MP0002723_abnormal_immune_serum | 0.89234964 |
| 119 | MP0003172_abnormal_lysosome_physiology | 0.88576113 |
| 120 | MP0010094_abnormal_chromosome_stability | 0.88479807 |
| 121 | MP0002019_abnormal_tumor_incidence | 0.87794348 |
| 122 | MP0002009_preneoplasia | 0.87613607 |
| 123 | MP0000689_abnormal_spleen_morphology | 0.87541959 |
| 124 | MP0001929_abnormal_gametogenesis | 0.87467359 |
| 125 | MP0003718_maternal_effect | 0.87350402 |
| 126 | MP0001672_abnormal_embryogenesis/_devel | 0.87119663 |
| 127 | MP0005380_embryogenesis_phenotype | 0.87119663 |
| 128 | MP0008469_abnormal_protein_level | 0.87020749 |
| 129 | MP0005551_abnormal_eye_electrophysiolog | 0.86858562 |
| 130 | MP0002909_abnormal_adrenal_gland | 0.86502699 |
| 131 | MP0001853_heart_inflammation | 0.85820996 |
| 132 | MP0008875_abnormal_xenobiotic_pharmacok | 0.85681239 |
| 133 | MP0002722_abnormal_immune_system | 0.85078552 |
| 134 | MP0002254_reproductive_system_inflammat | 0.84825649 |
| 135 | MP0005319_abnormal_enzyme/_coenzyme | 0.84766759 |
| 136 | MP0001243_abnormal_dermal_layer | 0.84476348 |
| 137 | MP0004133_heterotaxia | 0.84419517 |
| 138 | MP0005645_abnormal_hypothalamus_physiol | 0.83304963 |
| 139 | MP0001819_abnormal_immune_cell | 0.82318236 |
| 140 | MP0002420_abnormal_adaptive_immunity | 0.82118809 |
| 141 | MP0001324_abnormal_eye_pigmentation | 0.81619084 |
| 142 | MP0005167_abnormal_blood-brain_barrier | 0.81270587 |
| 143 | MP0002876_abnormal_thyroid_physiology | 0.81118139 |
| 144 | MP0008438_abnormal_cutaneous_collagen | 0.80481563 |
| 145 | MP0010329_abnormal_lipoprotein_level | 0.80133641 |
| 146 | MP0003011_delayed_dark_adaptation | 0.79837671 |
| 147 | MP0001216_abnormal_epidermal_layer | 0.78450493 |
| 148 | MP0002928_abnormal_bile_duct | 0.78029163 |
| 149 | MP0009763_increased_sensitivity_to | 0.77504094 |
| 150 | MP0001697_abnormal_embryo_size | 0.76659719 |
| 151 | MP0009643_abnormal_urine_homeostasis | 0.76264751 |
| 152 | MP0009053_abnormal_anal_canal | 0.76202575 |
| 153 | MP0008995_early_reproductive_senescence | 0.75866874 |
| 154 | MP0003795_abnormal_bone_structure | 0.75849354 |
| 155 | MP0000716_abnormal_immune_system | 0.75468953 |
| 156 | MP0002429_abnormal_blood_cell | 0.75300160 |
| 157 | MP0002080_prenatal_lethality | 0.75026071 |
| 158 | MP0005220_abnormal_exocrine_pancreas | 0.74093647 |
| 159 | MP0003890_abnormal_embryonic-extraembry | 0.72288625 |
| 160 | MP0003283_abnormal_digestive_organ | 0.71298401 |
| 161 | MP0005187_abnormal_penis_morphology | 0.69499836 |
| 162 | MP0005647_abnormal_sex_gland | 0.69073263 |
| 163 | MP0002078_abnormal_glucose_homeostasis | 0.68544223 |
| 164 | MP0008872_abnormal_physiological_respon | 0.67068570 |
| 165 | MP0005174_abnormal_tail_pigmentation | 0.67008701 |
| 166 | MP0001756_abnormal_urination | 0.66961714 |
| 167 | MP0002736_abnormal_nociception_after | 0.66927209 |
| 168 | MP0000631_abnormal_neuroendocrine_gland | 0.66816487 |
| 169 | MP0002166_altered_tumor_susceptibility | 0.66016416 |
| 170 | MP0004924_abnormal_behavior | 0.62058597 |
| 171 | MP0005386_behavior/neurological_phenoty | 0.62058597 |
| 172 | MP0010386_abnormal_urinary_bladder | 0.59825740 |
| 173 | MP0005391_vision/eye_phenotype | 0.59479063 |
| 174 | MP0001968_abnormal_touch/_nociception | 0.59340422 |
| 175 | MP0001501_abnormal_sleep_pattern | 0.58300590 |
| 176 | MP0005332_abnormal_amino_acid | 0.58174553 |
| 177 | MP0000015_abnormal_ear_pigmentation | 0.57644274 |
| 178 | MP0002006_tumorigenesis | 0.57265700 |
| 179 | MP0000653_abnormal_sex_gland | 0.56982616 |
| 180 | MP0001764_abnormal_homeostasis | 0.56301092 |
| 181 | MP0003698_abnormal_male_reproductive | 0.56222724 |
| 182 | MP0004270_analgesia | 0.55807710 |
| 183 | MP0009703_decreased_birth_body | 0.54385068 |
| 184 | MP0006036_abnormal_mitochondrial_physio | 0.52906216 |
| 185 | MP0003633_abnormal_nervous_system | 0.51989745 |
| 186 | MP0001486_abnormal_startle_reflex | 0.50827302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoplasia of the fovea (HP:0007750) | 5.41498268 |
| 2 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 5.41498268 |
| 3 | Abnormality of the fovea (HP:0000493) | 4.36144103 |
| 4 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.26455931 |
| 5 | Hypoglycemic seizures (HP:0002173) | 4.23337580 |
| 6 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.35792996 |
| 7 | Aqueductal stenosis (HP:0002410) | 3.34857956 |
| 8 | Intestinal atresia (HP:0011100) | 3.32783229 |
| 9 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.27760206 |
| 10 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.27760206 |
| 11 | Symptomatic seizures (HP:0011145) | 3.21893643 |
| 12 | Hypothermia (HP:0002045) | 3.11493621 |
| 13 | Hyperglycemia (HP:0003074) | 3.06788019 |
| 14 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.05336641 |
| 15 | Ketoacidosis (HP:0001993) | 3.03536446 |
| 16 | Myocardial infarction (HP:0001658) | 3.03236409 |
| 17 | Neoplasm of the adrenal cortex (HP:0100641) | 2.99690585 |
| 18 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.98889752 |
| 19 | Xanthomatosis (HP:0000991) | 2.82255890 |
| 20 | Eczematoid dermatitis (HP:0000976) | 2.80423716 |
| 21 | Breast carcinoma (HP:0003002) | 2.71987223 |
| 22 | Congenital malformation of the right heart (HP:0011723) | 2.69038260 |
| 23 | Double outlet right ventricle (HP:0001719) | 2.69038260 |
| 24 | Thyroiditis (HP:0100646) | 2.67828340 |
| 25 | Deep venous thrombosis (HP:0002625) | 2.59465228 |
| 26 | Esophageal varix (HP:0002040) | 2.58517779 |
| 27 | Optic nerve hypoplasia (HP:0000609) | 2.57553809 |
| 28 | Hamartoma of the eye (HP:0010568) | 2.56141271 |
| 29 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.54382640 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 2.48071000 |
| 31 | Pancreatic cysts (HP:0001737) | 2.46031272 |
| 32 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.45264709 |
| 33 | Osteolytic defects of the hand bones (HP:0009699) | 2.45006331 |
| 34 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.45006331 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.44357942 |
| 36 | Methylmalonic acidemia (HP:0002912) | 2.43693621 |
| 37 | Conjunctival hamartoma (HP:0100780) | 2.41241845 |
| 38 | Hip dysplasia (HP:0001385) | 2.36521366 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 2.34942170 |
| 40 | Biliary tract neoplasm (HP:0100574) | 2.33531924 |
| 41 | Ulnar bowing (HP:0003031) | 2.33431296 |
| 42 | Increased density of long bones (HP:0006392) | 2.32032829 |
| 43 | Axonal loss (HP:0003447) | 2.31333283 |
| 44 | Neoplasm of the adrenal gland (HP:0100631) | 2.31212728 |
| 45 | Cervical subluxation (HP:0003308) | 2.31204895 |
| 46 | Subacute progressive viral hepatitis (HP:0006572) | 2.29324374 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 2.28775546 |
| 48 | Abnormality of the common coagulation pathway (HP:0010990) | 2.28477980 |
| 49 | Tetraparesis (HP:0002273) | 2.24021115 |
| 50 | Thyroid carcinoma (HP:0002890) | 2.23285463 |
| 51 | Cerebral aneurysm (HP:0004944) | 2.23044299 |
| 52 | Enlarged penis (HP:0000040) | 2.22554315 |
| 53 | Intrahepatic cholestasis (HP:0001406) | 2.22163193 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.20884965 |
| 55 | Mucopolysacchariduria (HP:0008155) | 2.20884965 |
| 56 | Hematochezia (HP:0002573) | 2.18654006 |
| 57 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.18047600 |
| 58 | Increased mean platelet volume (HP:0011877) | 2.15025912 |
| 59 | Metaphyseal cupping (HP:0003021) | 2.14987107 |
| 60 | Progressive inability to walk (HP:0002505) | 2.13295847 |
| 61 | Stomatitis (HP:0010280) | 2.12248267 |
| 62 | Peritonitis (HP:0002586) | 2.12115329 |
| 63 | Reticulocytosis (HP:0001923) | 2.11495403 |
| 64 | Interstitial pulmonary disease (HP:0006530) | 2.08874933 |
| 65 | Abnormal platelet volume (HP:0011876) | 2.08446135 |
| 66 | Curly hair (HP:0002212) | 2.08279863 |
| 67 | Meningioma (HP:0002858) | 2.07709138 |
| 68 | Hand muscle atrophy (HP:0009130) | 2.06920887 |
| 69 | Prominent metopic ridge (HP:0005487) | 2.04522929 |
| 70 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.03775248 |
| 71 | Flat acetabular roof (HP:0003180) | 2.03652538 |
| 72 | Tongue fasciculations (HP:0001308) | 2.03346968 |
| 73 | Rhabdomyosarcoma (HP:0002859) | 2.03198196 |
| 74 | Abnormality of complement system (HP:0005339) | 2.03126202 |
| 75 | Hepatocellular carcinoma (HP:0001402) | 2.01343704 |
| 76 | Back pain (HP:0003418) | 2.01107921 |
| 77 | Large for gestational age (HP:0001520) | 2.00933713 |
| 78 | Abnormal pancreas size (HP:0012094) | 2.00738284 |
| 79 | Abnormality of vitamin B metabolism (HP:0004340) | 2.00639084 |
| 80 | True hermaphroditism (HP:0010459) | 1.99947235 |
| 81 | Pustule (HP:0200039) | 1.99816164 |
| 82 | Distal upper limb amyotrophy (HP:0007149) | 1.99300017 |
| 83 | Upper limb amyotrophy (HP:0009129) | 1.99300017 |
| 84 | Abnormality of macrophages (HP:0004311) | 1.99219082 |
| 85 | EEG with generalized epileptiform discharges (HP:0011198) | 1.97836983 |
| 86 | Abnormality of the metopic suture (HP:0005556) | 1.97549878 |
| 87 | Ketosis (HP:0001946) | 1.97251349 |
| 88 | Hypsarrhythmia (HP:0002521) | 1.95567825 |
| 89 | Abnormality of chromosome stability (HP:0003220) | 1.95406162 |
| 90 | Increased serum ferritin (HP:0003281) | 1.95386193 |
| 91 | Ependymoma (HP:0002888) | 1.94457864 |
| 92 | Premature rupture of membranes (HP:0001788) | 1.94363746 |
| 93 | Dysostosis multiplex (HP:0000943) | 1.94066750 |
| 94 | Global brain atrophy (HP:0002283) | 1.92655333 |
| 95 | Spastic diplegia (HP:0001264) | 1.92570447 |
| 96 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.92200281 |
| 97 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.92200281 |
| 98 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.92200281 |
| 99 | Recurrent viral infections (HP:0004429) | 1.90898607 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 1.90784830 |
| 101 | Progressive macrocephaly (HP:0004481) | 1.90527448 |
| 102 | Pancreatic fibrosis (HP:0100732) | 1.90085476 |
| 103 | Epileptiform EEG discharges (HP:0011182) | 1.87452739 |
| 104 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.87113412 |
| 105 | Recurrent abscess formation (HP:0002722) | 1.84397399 |
| 106 | Persistence of primary teeth (HP:0006335) | 1.84333194 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83954964 |
| 108 | Abnormal platelet function (HP:0011869) | 1.82857648 |
| 109 | Impaired platelet aggregation (HP:0003540) | 1.82857648 |
| 110 | Muscular hypotonia of the trunk (HP:0008936) | 1.81883152 |
| 111 | Furrowed tongue (HP:0000221) | 1.81702545 |
| 112 | Pendular nystagmus (HP:0012043) | 1.81661264 |
| 113 | Thoracolumbar scoliosis (HP:0002944) | 1.81450206 |
| 114 | Poikilocytosis (HP:0004447) | 1.80961894 |
| 115 | Albinism (HP:0001022) | 1.80946620 |
| 116 | Hypomagnesemia (HP:0002917) | 1.80351967 |
| 117 | Abnormal foot bone ossification (HP:0010675) | 1.80248336 |
| 118 | Fair hair (HP:0002286) | 1.79532632 |
| 119 | Abnormal cartilage morphology (HP:0002763) | 1.79445300 |
| 120 | Multiple enchondromatosis (HP:0005701) | 1.78825131 |
| 121 | Abnormality of the parathyroid morphology (HP:0011766) | 1.78066415 |
| 122 | Abnormal biliary tract morphology (HP:0012440) | 1.77762343 |
| 123 | Hydroxyprolinuria (HP:0003080) | 1.76710151 |
| 124 | Abnormality of proline metabolism (HP:0010907) | 1.76710151 |
| 125 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.76621363 |
| 126 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.76234215 |
| 127 | Gaze-evoked nystagmus (HP:0000640) | 1.75881688 |
| 128 | Papillary thyroid carcinoma (HP:0002895) | 1.75727067 |
| 129 | Uterine neoplasm (HP:0010784) | 1.75709270 |
| 130 | Recurrent bacterial skin infections (HP:0005406) | 1.75621635 |
| 131 | Abnormality of the intrinsic pathway (HP:0010989) | 1.75011551 |
| 132 | Hypercholesterolemia (HP:0003124) | 1.74810910 |
| 133 | Protrusio acetabuli (HP:0003179) | 1.74732549 |
| 134 | Joint hemorrhage (HP:0005261) | 1.74441306 |
| 135 | Methylmalonic aciduria (HP:0012120) | 1.74318320 |
| 136 | Cupped ribs (HP:0000887) | 1.74248638 |
| 137 | Complement deficiency (HP:0004431) | 1.73105698 |
| 138 | T lymphocytopenia (HP:0005403) | 1.71890220 |
| 139 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.71017062 |
| 140 | Hypobetalipoproteinemia (HP:0003563) | 1.70122112 |
| 141 | Optic nerve coloboma (HP:0000588) | 1.69301927 |
| 142 | Recurrent fungal infections (HP:0002841) | 1.69012277 |
| 143 | Abnormality of the preputium (HP:0100587) | 1.68614662 |
| 144 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.68144542 |
| 145 | Mutism (HP:0002300) | 1.67940087 |
| 146 | Meckel diverticulum (HP:0002245) | 1.67668962 |
| 147 | Abnormality of the labia minora (HP:0012880) | 1.67298245 |
| 148 | Micronodular cirrhosis (HP:0001413) | 1.67224611 |
| 149 | Severe short stature (HP:0003510) | 1.66669432 |
| 150 | Polycythemia (HP:0001901) | 1.66532523 |
| 151 | Menorrhagia (HP:0000132) | 1.64709858 |
| 152 | Aneurysm (HP:0002617) | 1.64553682 |
| 153 | Oligodactyly (hands) (HP:0001180) | 1.64001052 |
| 154 | Abnormality of the astrocytes (HP:0100707) | 1.63465215 |
| 155 | Astrocytoma (HP:0009592) | 1.63465215 |
| 156 | Abnormality of the renal cortex (HP:0011035) | 1.63214272 |
| 157 | Abnormality of the ileum (HP:0001549) | 1.63172898 |
| 158 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.63146775 |
| 159 | Peripheral demyelination (HP:0011096) | 1.63013270 |
| 160 | Radial bowing (HP:0002986) | 1.62742120 |
| 161 | Congenital stationary night blindness (HP:0007642) | 1.62528931 |
| 162 | Disinhibition (HP:0000734) | 1.62500867 |
| 163 | Adenoma sebaceum (HP:0009720) | 1.62476249 |
| 164 | Angiofibromas (HP:0010615) | 1.62476249 |
| 165 | Generalized myoclonic seizures (HP:0002123) | 1.61478996 |
| 166 | Abnormality of T cell number (HP:0011839) | 1.61477594 |
| 167 | Muscle fibrillation (HP:0010546) | 1.61474023 |
| 168 | Genu recurvatum (HP:0002816) | 1.61419422 |
| 169 | Mitral valve prolapse (HP:0001634) | 1.61396325 |
| 170 | Vertebral clefting (HP:0008428) | 1.60985637 |
| 171 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.59682553 |
| 172 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.59586451 |
| 173 | Difficulty running (HP:0009046) | 1.59275447 |
| 174 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.59240698 |
| 175 | Ulnar deviation of the wrist (HP:0003049) | 1.59221224 |
| 176 | Hypoglycemic coma (HP:0001325) | 1.59165235 |
| 177 | Ovarian neoplasm (HP:0100615) | 1.59103703 |
| 178 | Pseudobulbar signs (HP:0002200) | 1.58658613 |
| 179 | Disproportionate short-trunk short stature (HP:0003521) | 1.58505314 |
| 180 | Abnormality of the duodenum (HP:0002246) | 1.58466246 |
| 181 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.58116279 |
| 182 | Cutaneous melanoma (HP:0012056) | 1.57489477 |
| 183 | Nephronophthisis (HP:0000090) | 1.56361441 |
| 184 | Gingival bleeding (HP:0000225) | 1.56352020 |
| 185 | Generalized hyperpigmentation (HP:0007440) | 1.56088081 |
| 186 | Systemic lupus erythematosus (HP:0002725) | 1.55773569 |
| 187 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.55541025 |
| 188 | Gastrointestinal carcinoma (HP:0002672) | 1.55541025 |
| 189 | Increased CSF protein (HP:0002922) | 1.55409509 |
| 190 | Epidermoid cyst (HP:0200040) | 1.55314557 |
| 191 | Thoracic kyphosis (HP:0002942) | 1.55178011 |
| 192 | Upper motor neuron abnormality (HP:0002127) | 1.54863650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 3.66745719 |
| 2 | EIF2AK3 | 3.55779020 |
| 3 | MST4 | 3.12186999 |
| 4 | TRIB3 | 2.96344332 |
| 5 | ERN1 | 2.83523588 |
| 6 | CDK12 | 2.63497347 |
| 7 | TNIK | 2.62604072 |
| 8 | WNK3 | 2.51924775 |
| 9 | PKN2 | 2.46300794 |
| 10 | MKNK2 | 2.43588463 |
| 11 | ACVR1B | 2.40456114 |
| 12 | MAP3K10 | 2.38228740 |
| 13 | EPHA2 | 2.33831402 |
| 14 | EEF2K | 2.32012945 |
| 15 | ERBB3 | 2.26804300 |
| 16 | MAP4K2 | 2.18588499 |
| 17 | FGFR2 | 2.15848150 |
| 18 | MAPK13 | 2.14157777 |
| 19 | SIK3 | 2.12536532 |
| 20 | RPS6KA4 | 2.03145383 |
| 21 | STK10 | 1.99237037 |
| 22 | PLK2 | 1.98876208 |
| 23 | TAOK3 | 1.89695449 |
| 24 | INSRR | 1.82914504 |
| 25 | MAP3K3 | 1.80924190 |
| 26 | PTK6 | 1.72128868 |
| 27 | PLK3 | 1.70804211 |
| 28 | BMPR1B | 1.69396982 |
| 29 | PTK2B | 1.59200450 |
| 30 | STK38L | 1.55407846 |
| 31 | CDK6 | 1.53618597 |
| 32 | STK24 | 1.53579144 |
| 33 | GRK1 | 1.52179409 |
| 34 | MKNK1 | 1.51941681 |
| 35 | FER | 1.50737050 |
| 36 | MAP2K3 | 1.49260832 |
| 37 | LRRK2 | 1.45867316 |
| 38 | LATS1 | 1.42286643 |
| 39 | RIPK1 | 1.41695385 |
| 40 | NUAK1 | 1.41498219 |
| 41 | EIF2AK1 | 1.40265816 |
| 42 | TBK1 | 1.39836334 |
| 43 | STK3 | 1.39568775 |
| 44 | FGFR4 | 1.39084754 |
| 45 | MAP3K14 | 1.35109782 |
| 46 | TTN | 1.32951495 |
| 47 | NEK9 | 1.32148765 |
| 48 | MAP4K1 | 1.31949307 |
| 49 | FLT3 | 1.31869315 |
| 50 | STK39 | 1.30129426 |
| 51 | TYK2 | 1.28460583 |
| 52 | MAP3K8 | 1.27767327 |
| 53 | NEK2 | 1.27669317 |
| 54 | CSNK1G1 | 1.27577775 |
| 55 | NME2 | 1.25735209 |
| 56 | SCYL2 | 1.25128008 |
| 57 | OXSR1 | 1.24561697 |
| 58 | PAK3 | 1.24321291 |
| 59 | RPS6KB2 | 1.23049172 |
| 60 | JAK3 | 1.22711039 |
| 61 | SRPK1 | 1.22654141 |
| 62 | BRD4 | 1.18628667 |
| 63 | PIM2 | 1.18627978 |
| 64 | BCR | 1.18580028 |
| 65 | MAP3K4 | 1.17479432 |
| 66 | TSSK6 | 1.16242265 |
| 67 | ALK | 1.16106884 |
| 68 | BMX | 1.15087984 |
| 69 | EPHB1 | 1.14929846 |
| 70 | CDK4 | 1.14809693 |
| 71 | ZAP70 | 1.11561192 |
| 72 | IRAK3 | 1.11196214 |
| 73 | PDGFRA | 1.09733812 |
| 74 | CSNK1G3 | 1.09720822 |
| 75 | PAK4 | 1.05552574 |
| 76 | IRAK2 | 1.05390653 |
| 77 | YES1 | 1.04669764 |
| 78 | CSNK1G2 | 1.04219442 |
| 79 | PASK | 1.04174793 |
| 80 | ADRBK2 | 1.03844806 |
| 81 | MTOR | 1.03833027 |
| 82 | MST1R | 1.03058714 |
| 83 | PIM1 | 1.02695453 |
| 84 | MAPKAPK3 | 1.02141697 |
| 85 | SIK1 | 0.99644412 |
| 86 | FRK | 0.99572187 |
| 87 | CDC7 | 0.99114848 |
| 88 | CSK | 0.97968964 |
| 89 | MET | 0.96045207 |
| 90 | TGFBR2 | 0.94916360 |
| 91 | CSNK1A1L | 0.88427827 |
| 92 | MAP3K11 | 0.88038542 |
| 93 | TESK1 | 0.87372512 |
| 94 | CAMK1D | 0.86858846 |
| 95 | BLK | 0.86755609 |
| 96 | PAK2 | 0.85673532 |
| 97 | BUB1 | 0.84353545 |
| 98 | DYRK1B | 0.84314184 |
| 99 | PNCK | 0.84084430 |
| 100 | CHUK | 0.84056909 |
| 101 | PLK4 | 0.83660524 |
| 102 | PINK1 | 0.83614408 |
| 103 | STK4 | 0.83530020 |
| 104 | PTK2 | 0.82909229 |
| 105 | ERBB4 | 0.80864518 |
| 106 | ZAK | 0.79970004 |
| 107 | AKT3 | 0.77205234 |
| 108 | CASK | 0.77144916 |
| 109 | KDR | 0.76636659 |
| 110 | BRSK2 | 0.75793413 |
| 111 | FGFR3 | 0.75474754 |
| 112 | ITK | 0.73076746 |
| 113 | TTK | 0.71445173 |
| 114 | PHKG2 | 0.71368489 |
| 115 | PHKG1 | 0.71368489 |
| 116 | JAK2 | 0.69800943 |
| 117 | JAK1 | 0.69210687 |
| 118 | PDK2 | 0.69181422 |
| 119 | IKBKB | 0.67512416 |
| 120 | GRK6 | 0.67084930 |
| 121 | TAOK1 | 0.66285146 |
| 122 | TAF1 | 0.65198685 |
| 123 | PRKCE | 0.63423954 |
| 124 | MAP2K2 | 0.63399132 |
| 125 | CDK7 | 0.63086741 |
| 126 | BMPR2 | 0.61605310 |
| 127 | EGFR | 0.61482693 |
| 128 | TESK2 | 0.61327441 |
| 129 | PDGFRB | 0.61097839 |
| 130 | MELK | 0.60353004 |
| 131 | WEE1 | 0.60269101 |
| 132 | HIPK2 | 0.60173109 |
| 133 | MARK3 | 0.58100995 |
| 134 | CDK3 | 0.57326784 |
| 135 | GSK3A | 0.57032964 |
| 136 | PRKCG | 0.55929213 |
| 137 | TRPM7 | 0.55809453 |
| 138 | MAP2K7 | 0.55671273 |
| 139 | EIF2AK2 | 0.55654633 |
| 140 | MAP3K5 | 0.54729374 |
| 141 | IRAK4 | 0.54011244 |
| 142 | TGFBR1 | 0.53201753 |
| 143 | DYRK3 | 0.52355101 |
| 144 | SGK2 | 0.52216703 |
| 145 | BTK | 0.50716321 |
| 146 | PLK1 | 0.50338177 |
| 147 | MAPKAPK2 | 0.50261043 |
| 148 | CDK9 | 0.50218670 |
| 149 | HCK | 0.48978336 |
| 150 | MAP3K2 | 0.48056313 |
| 151 | MAPK11 | 0.47892167 |
| 152 | AURKB | 0.46190709 |
| 153 | CSF1R | 0.45673008 |
| 154 | LCK | 0.41677543 |
| 155 | CHEK1 | 0.40338825 |
| 156 | PRKCI | 0.40224698 |
| 157 | ATM | 0.39778460 |
| 158 | DDR2 | 0.38590221 |
| 159 | NLK | 0.38038045 |
| 160 | CSNK1D | 0.35883228 |
| 161 | IRAK1 | 0.35168918 |
| 162 | KSR1 | 0.32065617 |
| 163 | GRK7 | 0.27622370 |
| 164 | DAPK2 | 0.27609083 |
| 165 | CAMK1G | 0.27346470 |
| 166 | VRK1 | 0.27174122 |
| 167 | TXK | 0.26675008 |
| 168 | MAP3K9 | 0.26147097 |
| 169 | BRSK1 | 0.25923678 |
| 170 | CSNK1A1 | 0.25828328 |
| 171 | PRKAA2 | 0.25548916 |
| 172 | FGR | 0.25418215 |
| 173 | ABL1 | 0.24955469 |
| 174 | MARK1 | 0.24695365 |
| 175 | FGFR1 | 0.24574613 |
| 176 | SGK3 | 0.23084113 |
| 177 | MAP3K12 | 0.22383021 |
| 178 | MAP2K1 | 0.21782771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.78322996 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.23370531 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.47910135 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.41039990 |
| 5 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.39894105 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.17770302 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.02417944 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01111805 |
| 9 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.00409736 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.92837935 |
| 11 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.91745316 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.85647290 |
| 13 | Basal transcription factors_Homo sapiens_hsa03022 | 1.74779469 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.72926097 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.70855318 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.69653097 |
| 17 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.68023833 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.64283530 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.62098020 |
| 20 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.61469047 |
| 21 | RNA degradation_Homo sapiens_hsa03018 | 1.61347989 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59205731 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.55413554 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.53431972 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.52490179 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.52179796 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.51882737 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51174553 |
| 29 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.51160939 |
| 30 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.47789085 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.46921912 |
| 32 | Phototransduction_Homo sapiens_hsa04744 | 1.45254841 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44596006 |
| 34 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.41743750 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.40903099 |
| 36 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.38722330 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.36372755 |
| 38 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.33394833 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32811509 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.31727851 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 1.30826014 |
| 42 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.28524916 |
| 43 | Circadian rhythm_Homo sapiens_hsa04710 | 1.26858743 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.25388152 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.23802574 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18509781 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18462482 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.18342421 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17049498 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.16269951 |
| 51 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.15989254 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12432364 |
| 53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.10341314 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 1.10191357 |
| 55 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10017013 |
| 56 | Malaria_Homo sapiens_hsa05144 | 1.09090522 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.08481721 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 1.07931298 |
| 59 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06867922 |
| 60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.06409109 |
| 61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04740489 |
| 62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.03497820 |
| 63 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.03274978 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.02568625 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.02327093 |
| 66 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.01328365 |
| 67 | Homologous recombination_Homo sapiens_hsa03440 | 0.99672188 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.98368063 |
| 69 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.98111824 |
| 70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97054661 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.96529365 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96164474 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95545029 |
| 74 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.95498066 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94376321 |
| 76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.94372024 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.94084388 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.93997055 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 0.93469177 |
| 80 | Tuberculosis_Homo sapiens_hsa05152 | 0.91643523 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.90943689 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.89771270 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88971977 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.88523986 |
| 85 | Adherens junction_Homo sapiens_hsa04520 | 0.87411955 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87261893 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.86953816 |
| 88 | RNA transport_Homo sapiens_hsa03013 | 0.86715117 |
| 89 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.85990574 |
| 90 | Shigellosis_Homo sapiens_hsa05131 | 0.85226351 |
| 91 | Prostate cancer_Homo sapiens_hsa05215 | 0.84997310 |
| 92 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84457480 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84434235 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81806117 |
| 95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78692124 |
| 96 | Peroxisome_Homo sapiens_hsa04146 | 0.78163632 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76729113 |
| 98 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75859060 |
| 99 | Influenza A_Homo sapiens_hsa05164 | 0.75717909 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73688720 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73633261 |
| 102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73506533 |
| 103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.73198627 |
| 104 | Cell cycle_Homo sapiens_hsa04110 | 0.72507416 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | 0.72391853 |
| 106 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71075717 |
| 107 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70651169 |
| 108 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69986634 |
| 109 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69747682 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69394717 |
| 111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68479759 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.68255447 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68139630 |
| 114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68007689 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67684284 |
| 116 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67570691 |
| 117 | Asthma_Homo sapiens_hsa05310 | 0.66945346 |
| 118 | RNA polymerase_Homo sapiens_hsa03020 | 0.66564003 |
| 119 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65800610 |
| 120 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65328497 |
| 121 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64615653 |
| 122 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62938081 |
| 123 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62779749 |
| 124 | DNA replication_Homo sapiens_hsa03030 | 0.61933889 |
| 125 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61181658 |
| 126 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.60215776 |
| 127 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.60023712 |
| 128 | Focal adhesion_Homo sapiens_hsa04510 | 0.59275595 |
| 129 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59179268 |
| 130 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57954048 |
| 131 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57223052 |
| 132 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56365752 |
| 133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56249883 |
| 134 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.54530738 |
| 135 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53731611 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52818151 |
| 137 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52669191 |
| 138 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.52319553 |
| 139 | Phagosome_Homo sapiens_hsa04145 | 0.51942992 |
| 140 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.51277471 |
| 141 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51276161 |
| 142 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51065864 |
| 143 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.50617499 |
| 144 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50490133 |
| 145 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50294301 |
| 146 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.49673972 |
| 147 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.49199364 |
| 148 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.48814922 |
| 149 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48640969 |
| 150 | Salmonella infection_Homo sapiens_hsa05132 | 0.46439370 |
| 151 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.43848376 |
| 152 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41654827 |
| 153 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.41244466 |
| 154 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38406429 |
| 155 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38098894 |
| 156 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37967086 |
| 157 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36298051 |
| 158 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.32396007 |
| 159 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.31126477 |
| 160 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30877940 |
| 161 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.29660412 |
| 162 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28706733 |
| 163 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.26449865 |
| 164 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.25784691 |
| 165 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.24485276 |
| 166 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.23644425 |
| 167 | Purine metabolism_Homo sapiens_hsa00230 | 0.20874977 |

